RECARBRIO: payments to doctors
Payments that named RECARBRIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $819K
- Providers
- 8,098
- Transactions
- 22,286
- Average per transaction
- $37
The per-transaction average — $37 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,098 providers the average total is $101, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $819,480 | 100.0% |